Project IMPACT Immunizations (IMProving America's Communities Together)
NCT02584036 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1080
Last updated 2016-07-12
Summary
The primary objective of this study is to evaluate how implementing an innovative care model that provides the pharmacist access to a patient's vaccine history at the point-of-care impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations.
Conditions
Interventions
- BIOLOGICAL
-
Vaccine administration by a pharmacist
Administration, number and types, of vaccine(s) by a pharmacist
- BEHAVIORAL
-
Unmet vaccination needs identified and met
Identification of unmet vaccination needs and having those needs met
- BEHAVIORAL
-
Vaccination forecast review and patient education
Pharmacist review of the vaccination forecast and patient education on his/her vaccine needs
Sponsors & Collaborators
-
American Pharmacists Association Foundation
lead OTHER
Principal Investigators
-
Benjamin M Bluml, BPharm · American Pharmacists Association
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2016-04-30
- Completion
- 2016-07-31
Countries
- United States
Study Locations
More Related Trials
-
Revealing Protective Immunity to Influenza Using Systems Immunology
NCT06501963 ·Status: COMPLETED ·Phase: PHASE4
-
Immune Responses in Health Care Personnel
NCT03323112 ·Status: RECRUITING
-
Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCP
NCT03722589 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Biomarkers of Immune Activation Associated with Symptoms and Immune Responses After Influenza Vaccination in Adults
NCT03160118 ·Status: COMPLETED ·Phase: PHASE4
-
Retail COVID-19 Study
NCT06761612 ·Status: COMPLETED
-
Evaluation of the Effectiveness of Vaccination With 2009 H1N1 Vaccines During Influenza Season 2010-11
NCT01206114 ·Status: COMPLETED
-
Immune Response to Vaccination in Patients Receiving Single Drug Immunosuppression
NCT01733056 ·Status: COMPLETED ·Phase: NA
-
Nationwide Utilization of Danish Government Electronic Letter System for Confirming the Effectiveness of Behavioral Nudges in Increasing InFLUenza Vaccine Uptake Among Older Adults
NCT06030726 ·Status: COMPLETED ·Phase: NA
-
Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults
NCT01701752 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly Adults
NCT00386698 ·Status: COMPLETED ·Phase: PHASE2
-
Offering Influenza and Pneumococcal Vaccine to Patients Being Evaluated in the Emergency Department
NCT00380679 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluate Reactogenicity & Immunogenicity of an Influenza Pandemic Candidate Vaccine (GSK1562902A) in Primed Adults
NCT00506350 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Reactogenicity and Immunogenicity of Revaccination With Adjuvanted Influenza Vaccine in Elderly
NCT00386113 ·Status: COMPLETED ·Phase: PHASE2
-
Investigating the Effectiveness of a Seasonal Influenza Vaccination Promotion Campaign for Members of a Non-Profit, Community-Based Health Insurance Plan: 2018-2019
NCT03700281 ·Status: UNKNOWN ·Phase: NA
-
The Impact of Imprinting and Repeated Influenza Vaccination on Adaptive Immunity, Transcriptomics, and Metabolomics
NCT03686514 ·Status: TERMINATED ·Phase: PHASE4
-
Immunogenicity, Safety, and Tolerability of an MF59-Adjuvanted Versus Non-Adjuvanted Influenza Vaccines in Patients With Chronic Pulmonary Disease, Chronic Heart Disease, or Diabetes Mellitus
NCT01032395 ·Status: COMPLETED ·Phase: PHASE3
-
Th1 Response to Influenza: Aging and Vaccine Efficacy
NCT00396305 ·Status: TERMINATED ·Phase: PHASE4
-
Influenza Vaccine Uptake Among Healthcare Workers
NCT05521763 ·Status: UNKNOWN ·Phase: NA
-
Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults
NCT03743688 ·Status: COMPLETED
-
A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above
NCT01607112 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Response Following Seasonal Influenza Vaccination
NCT03163342 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Metabolic Syndrome on Flu Vaccine Efficacy
NCT02653495 ·Status: TERMINATED ·Phase: NA
-
Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake Among Adults With Chronic Disease
NCT06030739 ·Status: COMPLETED ·Phase: NA
-
Enhancing a Sustainable Pharmacy-based Immunization Program in Two States
NCT02615470 ·Status: COMPLETED ·Phase: NA
-
Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly Population
NCT00318058 ·Status: COMPLETED ·Phase: PHASE1